Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review

Clicks: 304
ID: 266709
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #4 of 48 articles by views in journal of antimicrobial chemotherapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Despite a comprehensive search of the literature, the authors failed to find sufficient evidence for providing guidelines on amikacin dosing and therapeutic dru
Reference Key
abi2016journalamikacin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jenkins, Abi;(BSAC Working Party on Therapeutic Drug Monitoring);Thomson, Alison H.;(BSAC Working Party on Therapeutic Drug Monitoring);Brown, Nicholas M.;(BSAC Working Party on Therapeutic Drug Monitoring);Semple, Yvonne;(BSAC Working Party on Therapeutic Drug Monitoring);Sluman, Christine;(BSAC Working Party on Therapeutic Drug Monitoring);MacGowan, Alasdair;(BSAC Working Party on Therapeutic Drug Monitoring);Lovering, Andrew M.;(BSAC Working Party on Therapeutic Drug Monitoring);Wiffen, Phil J.;(BSAC Working Party on Therapeutic Drug Monitoring);
Journal journal of antimicrobial chemotherapy
Year 2016
DOI
DOI not found
URL
https://dx.doi.org/10.1093%2Fjac%2Fdkw250
Keywords
systematic review National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine treatment outcome adult anti-bacterial agents / therapeutic use anti-bacterial agents / administration & dosage* dose-response relationship drug drug-related side effects and adverse reactions amikacin / adverse effects* anti-bacterial agents / adverse effects* drug monitoring* amikacin / therapeutic use amikacin / administration & dosage* anti-bacterial agents / blood amikacin / blood investigators=[] affs=[]) pmid:27494904 doi:10.1093/jac/dkw250 abi jenkins alison h thomson collabauthor(name='(bsac working party on therapeutic drug monitoring)' interrupted time series analysis

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.